View the latest AINV stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of APOLLO INVESTMENT CORPORATION. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.

Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Apollo Investment pays an annual dividend of $1.80 per share, with a dividend yield of 10.29%. AINV's most recent quarterly dividend payment was made to shareholders of record on Monday, January 6. Apollo Investment pays out 99.45% of its earnings out as a dividend. Share on Stocktwits. Apollo Investment (NASDAQ:AINV) Earnings Information. Apollo Investment last posted its quarterly earnings results on November 5th, 2019. The asset manager reported $0.53 earnings per share for the quarter, topping the consensus estimate of $0.42 by $0.11. 01/11/2019 · 5 Wall Street analysts have issued ratings and price targets for Apollo Investment in the last 12 months. Their average twelve-month price target is $16.60, suggesting that the stock has a possible downside of 5.31%. The high price target for AINV is $18.00 and the low price target for AINV is $14.00.

December 2019 Dividend Portfolio Update

Stock quote and company snapshot for CHIMERA INVESTMENT CORPORATION NEW (CIM), including profile, stock chart, recent news and events, analyst opinions, and research reports. In depth view into PSEC (Prospect Capital) stock including the latest price, news, dividend history, earnings information and financials. Create watchlists and get real-time prices and news updates for all your watchlist symbols. join the STCK.PRO community of +40.000 active users and discover the power of social financial news! Exploring Apollo Investment (Nasdaq:AINV) stock? View AINV's stock price, price target, dividend, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.

Exploring Apollo Investment (NASDAQ:AINV) stock? View AINV's stock price, price target, dividend, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.

Tyme Technologies Inc. Tyme Technologies, Inc. is a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to … 29/12/2019 · National General Holdings Corp. (NGHC) announced today that it has completed the previously announced sale of its Euro Accident Health and Care Insurance Sweden operation to an investor group arranged by Impilo AB, a Swedish investment company focused on …

Tyme Technologies Inc. Tyme Technologies, Inc. is a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to …

15 Feb 2018 from quantopian.pipeline.data.zacks import broker_ratings_free; from quantopian.pipeline.data.psychsignal import stocktwits; # Constraint  4 Nov 2010 When did Ben Bernanke say that? Seventeen months ago he did. He testified the following before congress: “Unless we demonstrate a strong  3 Jan 2016 Apollo Investment Corporation, AINV, 5.17. 4. 6.34, -4.54 ▽, 29, 30.42% On Stocktwits: http://stocktwits.com/LunaticTrader. Or find me on  8 Nov 2015 Apollo Investment Corporation, AINV, 5.86. 3. 6.67, -7.13 △, 21, 21.13% On Stocktwits: http://stocktwits.com/LunaticTrader. Or find me on  15 Dec 2019 (NASDAQ:AINV) Bought by Point72 Asset Management L.P. · Point72 Asset Management L.P. Acquires Shares of 25,600 Celestica Inc  13 Dec 2019 Apollo Investment (NASDAQ: AINV) stock hit a yearly high price of $17.43. The stock was up 0.2% for the day. Clarkson (OTC: CKNHF) shares  Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.

After the first hour of trading the major indices began to lose ground and, while they all finished up on the day, they were all also well off their highs.

01/11/2019 · 5 Wall Street analysts have issued ratings and price targets for Apollo Investment in the last 12 months. Their average twelve-month price target is $16.60, suggesting that the stock has a possible downside of 5.31%. The high price target for AINV is $18.00 and the low price target for AINV is $14.00. View the latest AINV stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of APOLLO INVESTMENT CORPORATION. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.

Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Real-time Insider Trading Stock Screener. Long and Short Trading Ideas using Insider Transaction Data. MRNS | Complete Marinus Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 13/08/2019 · Find the latest Heat Biologics, Inc. (HTBX) stock quote, history, news and other vital information to help you with your stock trading and investing. ImmunoGen shares rise on ovarian cancer study Shares of ImmunoGen Inc. gained 18% in afternoon trading after the biotechnology company announced that the Food and Drug Administration had cleared a trial for its investigational ovarian cancer drug to be used to support accelerated approval. 27/12/2019 · Great Elm Capital Corp. Common Stock (GECC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Aldeyra Therapeutics announces positive early results in trial of dry eye disease treatment Aldeyra Therapeutics Inc. shares rose more than 13% in premarket trade Tuesday before surrendering their gains, after the biotech reported positive results in the first part of a …